Detalles de la búsqueda
1.
Leptin/lipopolysaccharide-treated dendritic cell vaccine improved cellular immune responses in an animal model of breast cancer.
Immunopharmacol Immunotoxicol
; 46(1): 73-85, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647347
2.
Glycyrrhiza Glabra Extract Modulates Type 1 T Helper (TH1) and Regulatory T Cell-Related Immune Responses in an Animal Model of Breast Cancer.
Iran J Immunol
; 21(2): 132-146, 2024 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38800958
3.
Vaccination with celecoxib-treated dendritic cells improved cellular immune responses in an animal breast cancer model.
Adv Med Sci
; 68(1): 157-168, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37003235
4.
Apelin receptor antagonist boosts dendritic cell vaccine efficacy in controlling angiogenic, metastatic and apoptotic-related factors in 4T1 breast tumor-bearing mice.
Med Oncol
; 40(6): 179, 2023 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37188900
5.
STATs signaling pathways in dendritic cells: As potential therapeutic targets?
Int Rev Immunol
; : 1-22, 2023 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37886903
6.
Inhibition of apelin/APJ axis enhances the potential of dendritic cell-based vaccination to modulate TH1 and TH2 cell-related immune responses in an animal model of metastatic breast cancer.
Adv Med Sci
; 67(1): 170-178, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290873
Resultados
1 -
6
de 6
1
Próxima >
>>